The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor Charly Travers discuss topics across the investing world.
Charly has been looking for pharma stocks in Europe, and he's pleasantly surprised with some of the possibilities there. Novartis is one company he likes a lot. He discusses it here, along with his view of the long-term prospects for the company.
Health-care investors are always looking for the next big breakthrough. Motley Fool co-founder David Gardner recently identified a small-cap health-care company that he believes is poised for monster returns. To uncover this top pick today, enjoy the special free report "Discover the Next Rule-Breaking Multibagger." Don't miss out on this limited-time offer and your opportunity to discover this game-changing company before the market does. Click here to access your report -- it's totally free.
At the time thisarticle was published Charly Travers has no positions in the stocks mentioned above. John Reeves has no positions in the stocks mentioned above. The Motley Fool owns shares of Teva Pharmaceutical Industries.Motley Fool newsletter services recommendNovartis, Pfizer, and Teva Pharmaceutical Industries. Try any of our Foolish newsletter servicesfree for 30 days. We Fools may not all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.